TY - JOUR
T1 - Idiopathic Granulomatous Mastitis
AU - Dilaveri, Christina
AU - Degnim, Amy
AU - Lee, Christine
AU - Desimone, Daniel
AU - Moldoveanu, Dan
AU - Ghosh, Karthik
N1 - Publisher Copyright:
© 2024 Christina Dilaveri et al.
PY - 2024
Y1 - 2024
N2 - Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory disorder of the breast that is often underrecognized. The exact etiology and pathophysiology are unknown, but milk stasis is felt to play a role. Classically, this condition is noninfectious, but many cases are noted to be associated with Corynebacterium species. Most patients affected are parous women with a mean age of 35, and many have breastfed within five years of diagnosis. Patients typically present with a painful mass and symptoms of inflammation, and these features can sometimes mimic breast cancer. Biopsy is needed to make a definitive diagnosis, and noncaseating granulomas are found on core biopsy. Many patients have a waxing and waning course over a period of six months to two years. Goal of treatment is to avoid surgery given poor wound healing, high risk of recurrence, and poor cosmetic outcomes. Medical treatment is preferred and includes observation, antibiotics, steroids, and immune modulators such as methotrexate. In more recent years, topical and intralesional steroids have become the treatment of choice, with similar outcomes to oral steroids.
AB - Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory disorder of the breast that is often underrecognized. The exact etiology and pathophysiology are unknown, but milk stasis is felt to play a role. Classically, this condition is noninfectious, but many cases are noted to be associated with Corynebacterium species. Most patients affected are parous women with a mean age of 35, and many have breastfed within five years of diagnosis. Patients typically present with a painful mass and symptoms of inflammation, and these features can sometimes mimic breast cancer. Biopsy is needed to make a definitive diagnosis, and noncaseating granulomas are found on core biopsy. Many patients have a waxing and waning course over a period of six months to two years. Goal of treatment is to avoid surgery given poor wound healing, high risk of recurrence, and poor cosmetic outcomes. Medical treatment is preferred and includes observation, antibiotics, steroids, and immune modulators such as methotrexate. In more recent years, topical and intralesional steroids have become the treatment of choice, with similar outcomes to oral steroids.
UR - http://www.scopus.com/inward/record.url?scp=85183794750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183794750&partnerID=8YFLogxK
U2 - 10.1155/2024/6693720
DO - 10.1155/2024/6693720
M3 - Review article
C2 - 38304866
AN - SCOPUS:85183794750
SN - 1075-122X
VL - 2024
JO - Breast Journal
JF - Breast Journal
M1 - 6693720
ER -